Boston IVF Chief Scientific Officer Denny Sakkas, PhD Receives Prestigious 2025 ASRM Distinguished Researcher Award for Lifetime Contributions to Fertility Research

Sakkas’ work has significantly advanced the understanding and practice of fertility care worldwide

BOSTON--(BUSINESS WIRE)--Boston IVF, a member of the global IVI RMA Network, and one of the nation’s leading reproductive service providers and long-standing pioneer in IVF research, today announced that Chief Scientific Officer Denny Sakkas, PhD has been awarded the 2025 American Society of Reproductive Medicine (ASRM) Distinguished Researcher Award, one of the most prestigious awards in reproductive medicine, at the ASRM Scientific Congress & Expo, October 25-29 in San Antonio, Texas.

This award recognizes Dr. Sakkas for his groundbreaking research that has shaped modern understanding of sperm DNA damage, fertilization, early embryo development, and male infertility, among other important breakthroughs. Over the course of his career, his discoveries have deepened the scientific foundation of reproductive medicine and improved clinical practices worldwide. Most recently, his pioneering work in live imaging of human embryos provided new insights into embryo metabolism and cell lineage, advancing the science and leading to better IVF outcomes.

“Dr. Sakkas’ decades-long research in human IVF has made it possible for thousands of patients worldwide to realize their dream of building a family,” said Dr. Juan A García-Velasco, Global Chief Scientific Officer at IVI RMA Global. “A true giant in our field, a role model and a servant leader, his generosity as a mentor and educator continues to inspire countless developing physician-scientists, pushing the boundaries of reproductive medicine for generations to come. His contribution to this field is transformative.”

Denny Sakkas, PhD, has been at the forefront of IVF since the early 1980s, driving research, leading innovation and advancing reproductive medicine forward with significant impact. He earned his PhD under Professor Alan Trounson at Monash University, one of the world’s foremost reproductive research centers. During this time, he contributed to several innovations that became standard practice in IVF laboratories worldwide. Over the course of his career, Dr. Sakkas directed research laboratories and served as Scientific and Laboratory Director at IVF centers across Europe, the UK, and the United States. His research continues to drive innovation in reproduction, spanning basic science, translational work, and commercial applications. He is currently an Associate Professor at Yale University School of Medicine, in addition to his role as Chief Scientific Officer at Boston IVF and IVIRMA North America.

“It’s an incredible honor to be recognized by my peers in reproductive medicine,” said Denny Sakkas, PhD, Chief Scientific Officer at Boston IVF. “This field has evolved tremendously over the past few decades, and I’ve been fortunate to work alongside many brilliant colleagues dedicated to improving patient outcomes and advancing our understanding of human reproduction. I remain relentlessly committed to continue exploring new ways to translate research into meaningful advances for patients.”

About Boston IVF

Boston IVF is one of the largest and most experienced fertility networks in the United States, with more than 150,000 babies born since 1986. Founded as one of the nation's first private practice IVF centers, the Boston IVF network has grown to include 40 reproductive endocrinologists across nearly 30 centers throughout Massachusetts, Maine, New Hampshire, Rhode Island, New York, Delaware, Idaho, Indiana, North Carolina, Ohio, and Utah. A renowned innovator of reproductive technologies, advanced protocols, and cutting-edge research, Boston IVF has achieved numerous "firsts" in reproductive care. Its scientific and research arm continues to pave the way for breakthroughs in fertility care, and its accredited REI Fellowship Program has graduated numerous reproductive endocrinologists as part of its mission to train the next generation of fertility experts. In 2024, Boston IVF joined the global IVI RMA Network, contributing to the network's management of more than 20+ labs and 60 satellites across North America.

In 2025, Boston IVF was named one of Castle Connolly’s Top 5 Private Practices for Top Doctors in Reproductive Medicine in the Nation, a distinction that reflects the organization’s continued leadership in reproductive science, innovation, and compassionate care.

Follow Boston IVF on:
Instagram | Facebook | LinkedIn | X/Twitter